Sarepta Therapeutics
SRPT
#4401
Rank
S$3.02 B
Marketcap
S$28.85
Share price
-2.45%
Change (1 day)
-82.93%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2025 (TTM): -S$0.34 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are S$2.41 Billion. In 2024 the company made an earning of S$0.33 Billion, an increase over its 2023 earnings that were of -S$0.68 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.34 Billion-199.68%
2024 S$0.33 B-150.14%
2023 -S$0.68 Billion-24.62%
2022 -S$0.9 Billion64.69%
2021 -S$0.55 Billion-24.25%
2020 -S$0.72 Billion-22.53%
2019 -S$0.93 Billion96.87%
2018 -S$0.47 Billion645.68%
2017 -S$63.02 Million-81.81%
2016 -S$0.35 Billion21.47%
2015 -S$0.29 Billion62.04%
2014 -S$0.18 Billion21.26%
2013 -S$0.15 Billion60.93%
2012 -S$90.18 Million93.69%
2011 -S$46.56 Million71.58%
2010 -S$27.14 Million35.06%
2009 -S$20.1 Million-11.62%
2008 -S$22.74 Million-47.02%
2007 -S$42.91 Million0.38%
2006 -S$42.75 Million88.3%
2005 -S$22.7 Million-30.06%
2004 -S$32.46 Million32.69%
2003 -S$24.46 Million-25.52%
2002 -S$32.84 Million64.52%
2001 -S$19.97 Million50.4%
2000 -S$13.28 Million26.44%
1999 -S$10.5 Million8%
1998 -S$9.72 Million102.7%
1997 -S$4.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
S$12.81 B-4,020.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$0.48 B-248.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-S$0.72 Billion 118.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.58 Million-97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.16 B-151.68%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
S$0.96 B-393.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-S$1.43 Billion 336.56%๐Ÿ‡บ๐Ÿ‡ธ USA